SAN DIEGO, March 2, 2017 /PRNewswire/ -- NuVasive, Inc.
(NASDAQ: NUVA), a leading medical device company focused on
transforming spine surgery with minimally disruptive,
procedurally-integrated solutions, announced today that
management will participate in the following investor events in
March 2017:
- Cowen 37th Annual Health Care Conference at The Boston Marriott
Copley Place in Boston on
Tuesday, March 7, 2017 at
10:00 a.m. ET / 7:00 a.m. PT; and
- Barclays Global Health Care Healthcare Conference 2017 at the
Loews Miami Beach Hotel in Miami
on Tuesday, March 14, 2017 at
1:35 p.m. ET / 10:35 a.m. PT.
A live webcast of each presentation will be available online
from the Investor Relations page of the Company's website at
nuvasive.com, and replays of the presentation will remain available
on the website for 30 days after the applicable live webcast.
About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is
a world leader in minimally invasive, procedurally-integrated spine
solutions. From complex spinal deformity to degenerative spinal
conditions, NuVasive is transforming spine surgery with innovative
technologies designed to deliver reproducible and clinically proven
surgical outcomes. NuVasive's highly differentiated,
procedurally-integrated solutions include access instruments,
implantable hardware and software systems for surgical planning and
reconciliation technology that centers on achieving the global
alignment of the spine. With $962
million in revenues (2016), NuVasive has an approximate
2,300 person workforce in more than 40 countries around the world.
For more information, please visit www.nuvasive.com.
Forward-Looking Statements
NuVasive cautions
you that statements included in this news release and made during
the investor events referenced herein that are not a description of
historical facts are forward-looking statements that involve risks,
uncertainties, assumptions and other factors which, if they do not
materialize or prove correct, could cause NuVasive's results to
differ materially from historical results or those expressed or
implied by such forward-looking statements. The potential risks and
uncertainties which contribute to the uncertain nature of these
statements include, among others, risks associated with acceptance
of the Company's surgical products and procedures by spine
surgeons, development and acceptance of new products or product
enhancements, clinical and statistical verification of the benefits
achieved via the use of NuVasive's products (including the iGA™
platform), the Company's ability to effectually manage inventory as
it continues to release new products, its ability to recruit and
retain management and key personnel, and the other risks and
uncertainties more fully described in the Company's news releases
and periodic filings with the Securities and Exchange Commission.
NuVasive's public filings with the Securities and Exchange
Commission are available at www.sec.gov. NuVasive assumes no
obligation to update any forward-looking statement to reflect
events or circumstances arising after the date on which it was
made.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/nuvasive-to-participate-in-investor-events-in-march-2017-300417417.html
SOURCE NuVasive, Inc.